Top news of the week: 14.07.2020.

#BioTech #competitiveintelligence #COVID19 #marketing #pharmaceutical #AMR #pharma #competitivemarketing #strategy #healthcare

Healthcare

On Jul 9, 2020
@ABPI_UK shared
RT @IFPMA: Unlike #COVID19, #AMR is a predictable and preventable crisis. We must act together to rebuild the pipeline and ensure that the most promising and innovative antibiotics make it from the lab to patients, says @ThomasCueni: https://t.co/Pi30uZY3He. More on https://t.co/TB03DLU8js https://t.co/jpDnS4B3pP
Open

New AMR Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment of US$1 billion

New AMR Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment of US$1 billion

IFPMA » New AMR Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment of US$1 billion

On Jul 12, 2020
@BiotechSweden shared
BioSpace Global Roundup, July 9 https://t.co/MzTc8qTfnf https://t.co/zSMv6IezYq
Open

BioSpace Global Roundup, July 9

BioSpace Global Roundup, July 9

Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.

On Jul 13, 2020
@BiotechSweden shared
RT @ScienceNews: 6 months after learning the coronavirus’s genetic makeup, researchers may have vaccines that can defeat it soon. https://t.co/78PxcdqjRO
Open

A COVID-19 vaccine may come soon. Will the blistering pace backfire?

A COVID-19 vaccine may come soon. Will the blistering pace backfire?

Speed is essential, but not at the expense of safety and efficacy, experts warn. Sacrificing either could damage public trust.

On Jul 11, 2020
@BiotechSweden shared
RT @OneMedWorld: Evive Biotech Sees Positive Results in Phase III Trial for CIN in Breast Cancer Patients https://t.co/I8OX3IXrU6 https://t.co/bBP4j5d7gJ
Open

Evive Biotech Sees Positive Results in Phase III Trial for CIN in Breast Cancer Patients

Evive Biotech Sees Positive Results in Phase III Trial for CIN in Breast Cancer Patients

Evive Biotech announced today that its Phase III study investigating F-627 to treat chemotherapy-induced neutropenia (CIN) in breast cancer patients has met its primary and secondary ...

On Jul 7, 2020
@BiotechSweden shared
Cambridge biotech raises $110 million to advance treatment for blood cancer #BioTech via https://t.co/2sI0UxJbpn https://t.co/vwqIRinOaL
Open

Cambridge biotech raises $110 million to advance treatment for blood cancer

Cambridge biotech raises $110 million to advance treatment for blood cancer

COVID-19 has upended the economy, but biotechs with promising medical treatments are still attracting venture capital.

On Jul 13, 2020
@BiotechSweden shared
RT @_timos_: Biotech startup aiding COVID-19 fight with cutting-edge genetic testing - Deseret News https://t.co/UxT4ii1n0U >>> https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #biotech #pharma #pharmaceutical #healthcare #competitivemarketing https://t.co/KY0n1cK3ff
Open

Know thy enemy: Biotech startup joins fight against COVID-19 with cutting-edge genetic testing

Know thy enemy: Biotech startup joins fight against COVID-19 with cutting-edge genetic testing

IDbyDNA is advancing the realm of metagenomic testing and playing a role in the fight against COVID-19. The San Francisco-based startup has its lab operations at Salt Lake City’s Research ...

On Jul 12, 2020
@BiotechSweden shared
BioSpace Movers & Shakers, July 10 https://t.co/8IzRrhOuTl https://t.co/IWPfN73iVk
Open

BioSpace Movers & Shakers, July 10

BioSpace Movers & Shakers, July 10

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

On Jul 9, 2020
@BiotechSweden shared
Major VC Rounds For AI-driven Biotechs in 2020 #BioTech #startup via https://t.co/2sI0UxJbpn https://t.co/sdtGWZyItV
Open

Major VC Rounds For AI-driven Biotechs in 2020

Major VC Rounds For AI-driven Biotechs in 2020

However, there is still a lot going on in drug discovery and healthcare, and here I would like to specifically focus on artificial intelligence (AI)-driven biotech and health tech …